文献速递免疫规划传染病防控与疫情报告

通往更有效流感疫苗之路:最新研究与未来展望

The road to a more effective influenza vaccine: Up to date studies and future prospects.
PubMed 文献 · Vaccine · 2017-08-31

流感病毒频繁点突变和基因片段交换导致免疫逃逸与流行;接种疫苗是最有效干预,但疫苗株与流行株不匹配降低效力,且现行注射疫苗诱导血清IgG而不诱导呼吸道黏膜分泌型IgA。本文综述抗原设计、接种途径改变及抗体库评估等改进策略,指出全面理解疫苗作用机制和评估抗体质量与数量对研发通用流感疫苗至关重要。

要点

  • 流感病毒点突变和基因片段交换可逃逸既往免疫,导致流行和大流行。
  • 现行注射疫苗诱导血清IgG限制症状进展,但不诱导呼吸道黏膜分泌型IgA。
  • 血凝抑制试验仅测抗体数量,抗体库分析可评估抗体质量与数量。

核心结论

  • 全面理解各种疫苗作用机制对研发通用流感疫苗至关重要,评估疫苗诱导抗体的质量与数量是关键。

研究设计与样本

  • 本文为综述,检索并汇总流感疫苗改进相关的最新研究,涵盖抗原设计、接种途径改变及抗体库评估方法。

主要发现

  • 流感病毒基因组频繁点突变和毒株间基因片段偶尔交换帮助病毒逃逸既往免疫,导致流行和大流行。
  • 接种疫苗是最有效干预,但流行病毒与疫苗株不匹配降低疫苗效力。
  • 现行注射疫苗诱导血清IgG抗体限制流感症状进展,但不诱导呼吸道黏膜分泌型IgA抗体有效预防病毒感染。
  • 广谱中和抗体的发现推动了抗原设计研究,改变疫苗给药途径以提高效力的研究也已开展。
  • 目前疫苗评估依赖血凝抑制试验,仅测量产生的抗体数量。

关键数值与推荐

  • 抗体库由具有特定遗传或分子特征、对应其功能的抗体组成。
  • 遗传和功能相似的抗体可由多个暴露于相同刺激的个体产生。
  • 通过检查抗体库,可能以疫苗诱导的抗体反应质量与数量评估和比较多种疫苗策略。
  • 近期研究使用单细胞表达和高通量免疫球蛋白测序详细描绘抗体反应。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Influenza virus causes an acute respiratory infection in humans. Frequent point mutations in the influenza genome and occasional exchange of genetic segments between virus strains help the virus evade the pre-existing immunity, resulting in epidemics and pandemics. Although vaccination is the most effective intervention, mismatches between circulating viruses and vaccine strains reduce vaccine efficacy. Furthermore, current injectable vaccines induce IgG antibodies in serum (which limit progression of influenza symptoms) but not secretory IgA antibodies in the respiratory mucosa (which prevent virus infection efficiently). Therefore, numerous studies have attempted to improve influenza vaccines. The discovery of broadly neutralizing antibodies has progressed research into antigen design. Studies designed to improve vaccine efficacy by changing the vaccine administration route have also been conducted. A thorough understanding of the mechanisms underlying the action of various vaccines is essential if we are to develop a universal influenza vaccine. Therefore, evaluating the quality and quantity of antibodies induced by vaccines, which determine vaccine efficacy, is critical. However, at present vaccine evaluation relies on hemagglutination inhibition tests, which only measure the quantity of antibody produced. Antibody repertoires comprise a set of antibodies with specific genetic or molecular features that correspond to their functions. Genetically and functionally similar antibodies may be produced by multiple individuals exposed to an identical stimulus. Therefore, it may be possible to evaluate and compare multiple vaccine strategies in terms of the quality and quantity of an antibody response induced by a vaccine by examining antibody repertoires. Recent studies have used single cell expression and high-throughput immunoglobulin sequencing to provide a detailed picture of antibody responses. These novel methods may be critical for detailed characterization of antibody repertoires induced by various vaccination strategies.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Sano K, Ainai A, Suzuki T, et al. The road to a more effective influenza vaccine: Up to date studies and future prospects. Vaccine. 2017. PMID: 28866292. doi:10.1016/j.vaccine.2017.08.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。